Global Life Science Tools and Reagents Market 2022-2028
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global life science tools and reagents market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the life science tools and reagents industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product type, application, and region. The global market for life science tools and reagents can be segmented By product type life science tools, life science COVID-19 diagnostics products. Life science tools and reagents market is further segmented By applicationt animal models, bioinformatics, cell biology, epigenetics, genomics, imaging and microscopy, proteomics, stem cells, others. Among these, the genomics segment was accounted for the highest revenue generator in 2021. Based on region, the life science tools and reagents market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).
By product type:
- life science tools
- life science COVID-19 diagnostics products
By applicationt:
- animal models
- bioinformatics
- cell biology
- epigenetics
- genomics
- imaging and microscopy
- proteomics
- stem cells
- others
By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
The market research report covers the analysis of key stake holders of the global life science tools and reagents market. Some of the leading players profiled in the report include Abcam plc, Abnova Corp., Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corp., Bruker Corp., Carl Zeiss Inc., Charles River Laboratories Inc., Danaher Corp., GE Healthcare, GenOway S.A., Hitachi High-Tech Group, Illumina, Inc., JEOL Ltd., Labcorp Drug Development, Luminex Corporation, Merck KGaA (includes Sigma Aldrich), Novozymes Inc., Olympus Inc., Perkin Elmer Inc., Perkin Elmer Inc., Plus Therapeutics Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global life science tools and reagents market.
- To classify and forecast the global life science tools and reagents market based on product type, application, region.
- To identify drivers and challenges for the global life science tools and reagents market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global life science tools and reagents market.
- To identify and analyze the profile of leading players operating in the global life science tools and reagents market.
Why Choose This Report
- Gain a reliable outlook of the global life science tools and reagents market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT TYPE
Life science tools
Life science COVID-19 diagnostics products
PART 6. MARKET BREAKDOWN BY APPLICATION
Animal models
Bioinformatics
Cell biology
Epigenetics
Genomics
Imaging and microscopy
Proteomics
Stem cells
Others
PART 7. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 8. KEY COMPANIES
Abcam plc
Abnova Corp.
Agilent Technologies Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne Corp.
Bruker Corp.
Carl Zeiss Inc.
Charles River Laboratories Inc.
Danaher Corp.
GE Healthcare
GenOway S.A.
Hitachi High-Tech Group
Illumina, Inc.
JEOL Ltd.
Labcorp Drug Development
Luminex Corporation
Merck KGaA (includes Sigma Aldrich)
Novozymes Inc.
Olympus Inc.
Perkin Elmer Inc.
Perkin Elmer Inc.
Plus Therapeutics Inc.
Qiagen N.V.
Roche Holding AG
Shimadzu Corporation
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Waters Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Global Biobanking Market 2022-2028
Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and diseases. The global biobanking market
USD 2600 View ReportGlobal 3D Bioprinting Market 2022-2028
In 2021, the global 3d bioprinting market stood at USD 817 million. Recording a CAGR of 17.3% from 2022 to 2028, the worth is projected to reach ~USD 2,496 million
USD 2600 View ReportGlobal Protective Clothing for Life Sciences Market 2022 - Industry Briefing
According to market research study published by , the global protective clothing for life sciences market is expected to reach approximately USD 5,361 million, representing a CAGR of 5.6% during
USD 800 View ReportGlobal Life Science Analytics Market Research Report 2021-2025
Major factors contributing to the growth of the global life science analytics market include technological advancements, availability of big data in the life science industry, growing adoption of analytics solutions
USD 3200 View ReportFill The Form For Sample Request